baber/WOPTO huggingface dataset:
Patent NZ-512362-A (NZ)
Title: Electrical connectors
Inventor: DREWNICKI RICHARD
IPC: H01R13/627
Filed: 1999-12-16
Abstract: A telephone plug (1) having a resilient displaceable latch member (31) for retaining the plug in a corresponding socket is described. In one embodiment, both ends of the latch member are integrally moulded with the plug. In another embodiment one end of the latch member is integrally moulded with the plug and the other end is retained by a retention member (33) having a catch mechanism. The telephone plug (1) may be part of a telephone adapter.
Patent NZ-517084-A (NZ)
Title: Photoluminescent semiconductor materials
Inventor: ARMSTRONG DAVID W
IPC: H01L33/00
Filed: 1999-07-09
Abstract: Semiconductor materials are described, that have a porous texture are modified with a recognition element and produce a photoluminescent response on exposure to electromagnetic radiation. The recognition elements, which can be selected from biomolecular, organic and inorganic moieties, interact with a target analyte to produce a modulated photoluminescent response, as compared with that of semiconductor materials modified with a recognition element only.
Patent NZ-523073-A (NZ)
Title: Systems and methods for treating a mucosal surface
Inventor: HEDENSTROM JOHN CHARLES
IPC: A61P25/28
Filed: 2001-06-22
Abstract: A system for treating a condition associated with a mucosal surface, the system comprising an immune response modifier (IRM) compound chosen from imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, 1,2-bridged imidazoquinoline amines, and pharmaceutically acceptable salts thereof and an applicator device for applying the IRM compound to the mucosal surface. This system of IRM compounds and applicator may be used to treat conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia
Patent NZ-523549-A (NZ)
Title: Non-nucleoside reverse transcriptase inhibitors
Inventor: SIMONEAU BRUNO
IPC: A61K/
Filed: 2001-06-14
Abstract: Disclosed herein are compounds of formula (I), wherein R2 is selected from the group consisting of H, F, Cl, (C1-4) alkyl, (C3-4) cycloalkyl and CF3; R4 is H or Me; R5 is H, Me or Et, with the proviso that R4 and R5 are not both Me, and if R4 is Me then R5 cannot be Et; R11 is Et, cyclopropyl, propyl, isopropyl, or isobutyl; and Q is selected from the group consisting of (II), (III), (IV) and (V); and pharmaceutically acceptable salts thereof, as inhibitors of HIV reverse transcriptase, wild-type and several mutant strains.
Patent NZ-523877-A (NZ)
Title: Method for the preparation of citalopram
Inventor: PETERSEN HANS
IPC: A61P25/34
Filed: 2001-08-14
Abstract: A method of preparing citalopram is disclosed which is as follows. Reacting 5-carboxyphthalide successively with a Grignard reagent of 4-halo-fluorophenyl and a Grignard reagent of 3-halo-N, N-dimethyl-propylamine and then effecting ring closure of the resulting compound of Formula XI to a compound of Formula IV followed by the conversion of compound of formula IV into citalopram.
Patent NZ-528366-A (NZ)
Title: Method and apparatus for continuously forming dye sublimation images in solid substrates
Inventor: DRAKE JONATHAN C
IPC: B41M5/035
Filed: 2002-03-29
Abstract: A method for forming a dye sublimation image in a substrate with a dye carrier having an image formed thereon of a sublimatic dyestuff is provided. The image of the dye carrier is placed against a first surface of the substrate. The substrate and dye carrier are conveyed along a path with a first part and a second part. A continuous pressure is provided against the first surface of the substrate in the first part and second part of the path and therebetween. The dye carrier is heated to a sublimation temperature in the first part of the path. The dye carrier is then cooled to a depressure temperature in the second part of the path.
Patent NZ-528560-A (NZ)
Title: 3,7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds
Inventor: BARNWELL NEIL
IPC: A61P9/06
Filed: 2002-04-12
Abstract: There is provided substantially crystalline forms of 4-({3-[7-(3,3-dimethyl-2-oxobutyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]propyl}amino)benzo-nitrile; tert -butyl 2-{7-[3-(4-cyanoanilino)propyl]-9-oxa-3,7-diazabicyclo-[3.3.1]non-3-yl}ethylcarbamate; tert -butyl 2-{7-[4-(4-cyanophenyl)butyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethylcarbamate; or tert -butyl 2-{7-[(2 S )-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo-[3.3.1]non-3-yl}ethylcarbamate and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of cardiac arrhythmias. Processes for the preparation of these compounds are also disclosed.
Patent NZ-533892-A (NZ)
Title: Fusion polypeptide for expression in a host cell comprising a TolAIII domain and a non-TolA polypeptide, wherein the TolAIII domain is located towards the N-terminus of the fusion polypeptide and the non-TolA polypeptide is located towards the C-terminus
Inventor: GOKCE ISA
IPC: C07K19/00
Filed: 2003-01-10
Abstract: Disclosed is a fusion polypeptide for expression in a host cell, in which the fusion polypeptide has a basic structure, in sequence, an N-terminus, a TolAIII domain or a functional homologue, fragment or derivative thereof, a non-TolA protein partner other than a His tag, and a C-terminus. Also disclosed is DNA molecules encoding the polypeptide, expression vectors comprising the DNA molecules, cloning vectors and uses of the fusion polypeptide for immobilising or purifying the non-TolA protein partner.
Patent NZ-536013-A (NZ)
Title: Rotary cutting tool
Inventor: HECHT GIL
IPC: B23B31/02
Filed: 2003-05-19
Abstract: A rotary cutting tool (10) having a cutting head (16), a screw member (18) and a tool shank (20) is disclosed. The cutting head (16) has an axially directed through bore with locking wings protruding from the bore surface. Each locking wing has a sloping locking surface and a stopper with a stop surface. The screw member (18) has outwardly radially protruding clamping wings each having a sloping clamping surface, and an associated side abutment surface. The screw member is in threaded engagement with the tool shank, with the clamping wings and locking wings aligned in pairs with the locking and clamping surfaces of each pair in abutment, and with each stop surface in abutment with a given side abutment surface.
Patent NZ-537270-A (NZ)
Title: A dispenser
Inventor: MCLISKEY NIGEL HAIG
IPC: B65D83/26
Filed: 2003-06-10
Abstract: A dispenser, the dispenser having a dispenser head and a container containing spray material, the dispenser being formed such that the container can be detached from the dispenser head and refilled and/or replaced when the spray material is exhausted; the dispenser having solenoid valve means substantially enclosed in a substantially metallic locking cover means, the valve means being arranged to substantially facilitate movement of the spray material from the container to the dispenser head, and the cover means being arranged to intensify a magnetic field which, when the dispenser is in use, facilitates opening and closing of the valve means; the dispenser being formed such that it can be set so the valve means opens and closes automatically and periodically to release a flow of spray material from the container to the dispenser head such that spray material is released as a spray to an atmosphere outside of the dispenser.
Patent NZ-538183-A (NZ)
Title: Formulation comprising a sterilised culture filtrate recovered from fungal spawn aka peat moss, carbohydrate, potassium ions and carotene used to grow plants
Inventor: HIROMOTO BRYAN TOKUICHI
IPC: A01N63/04
Filed: 2003-07-16
Abstract: A substantially microbe-free composition containing plant growth regulators produced by culturing fungal spawn on high carbohydrate medium under suitable conditions. The culture filtrate is sterilized, formulated and used to enhance plant growth.
Patent NZ-538803-A (NZ)
Title: Method for extending the shelf life of perishable agricultural products and/or food
Inventor: STEFFEN HANSPETER
IPC: B65D51/16
Filed: 2003-08-16
Abstract: In order to extend the shelf life of perishable agricultural products and/or food, said agricultural products and/or food items are placed in a packaging container (10), a modified atmosphere is created within the packaging container, and the packaging container is sealed. The modified atmosphere is created such that it has a higher ozone concentration than normal ambient air. A method and a packaging which extend the shelf life of delicate agricultural products and/or food are also disclosed.
Patent NZ-539285-A (NZ)
Title: Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
Inventor: DUGGER HARRY A
IPC: A61K38/00
Filed: 2003-08-27
Abstract: Disclosed herein is a propellant free buccal spray composition for transmucosal administration of a pharmacologically active compound comprising: an active compound in an amount of between 0.001 and 60 percent by weight of the total composition selected from the group consisting of anti-diuretics, anti-spasmodics, agents for treating urinary incontinence, anti-diarrhoeal agents, agents for treating nausea and/or vomiting, smooth muscle contractile agents, anti-secretory agents, enzymes, anti-diuretics, anti-ulcerants, bile acid replacement and/or gallstone solubilizing drugs, and mixtures thereof; and a polar solvent in an amount between 30 and 99 percent by weight of the total composition. These propellant free buccal spray compositions are suitable for providing biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect.
Patent NZ-541727-A (NZ)
Title: Process for preparing indacterol
Inventor: LOHSE OLIVIER
IPC: C07D215/26
Filed: 2004-02-27
Abstract: Disclosed is a process for preparing 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1H)-quinolin-2-one (indacterol) salt without isolating the free base thereof which is unstable in organic solvents. The process comprises (i) reacting 8-substituted oxy-5-(R)-oxiranyl-(1H)-quinolin-2-one having Formula (I) wherein R is a protecting group with 2-amino-(5-6-diethyl)-indan to form a reaction mixture; (ii) treating the reaction mixture prepared in Step (i) with an acid selected from the group consisting of benzoic acid, maleic acid, succinic acid, fumaric acid, tartaric acid and hydrochloric acid in the presence of a solvent to form a corresponding salt; (iii) isolating and crystallizing a salt; (iv) removing the protecting group from the salt in the presence of a solvent; and (v) treating the salt with a carboxylic acid in the presence of a solvent to form a 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1H)-quinolin-2one salt having Formula (VII) wherein X- is an anion.
Patent NZ-542138-A (NZ)
Title: Heterobifunctional polymeric bioconjugates
Inventor: GREENWALD RICHARD B
IPC: A61K47/48
Filed: 2004-03-12
Abstract: Heterobifunctional polymeric prodrug platforms for delivering biologically active compounds, including proteins, monoclonal antibodies and the like are disclosed. One preferred compound is formula (I), wherein the substituents are as defined in the specification. Methods of making and using the compounds and conjugates described herein are also provided.
Patent NZ-543070-A (NZ)
Title: Modulation of cytokinin activity in plants
Inventor: HABBEN JEFFREY E
IPC: C12N9/10
Filed: 2004-04-02
Abstract: Provided is an isolated promoter capable of driving transcription in a seed-preferred manner, wherein the promoter comprises a specified sequence or a functional fragment thereof. Further provided are corresponding recombinant expression cassettes, plants stably transformed with the cassette, methods of producing such transgenic plants capable of the regulated expression of a cytokinin-modulating gene in developing seed.
Patent NZ-545385-A (NZ)
Title: Prion-specific peptide reagents
Inventor: MICHELITSCH MELISSA D
IPC: A23L13/00
Filed: 2004-08-13
Abstract: Provided is an in vitro method for detecting the presence of a conformational pathogenic prion disease protein in a sample, said method comprising: (a) contacting a sample suspected of comprising a conformational pathogenic prion disease protein with a peptide reagent that interacts preferentially with a pathogenic form of a conformational prion-related disease protein as compared to a non-pathogenic form of the conformational prion-related disease protein, wherein said contacting is under conditions that allow the binding of the peptide reagent to the pathogenic form of the conformational prion-related disease protein, if present, to thereby form a complex; and (b) detecting a complex comprising the pathogenic form of a conformational prion-related disease protein and the peptide reagent, wherein the peptide reagent comprises a specified sequence or between 3 and 100 consecutive amino acid residues of the specified sequence.
Patent NZ-553424-A (NZ)
Title: Permutation data transform to enhance security
Inventor: DAMGAARD IVAN BJERRE
Filed: 2005-08-09
Abstract: An apparatus for the permutation data transform to enhance security comprises an input port to receive a master key and an implementation of a universal hash algorithm. The implementation of a universal hash algorithm includes a divider to divide the master key into a first segment and a second segment; a repeater to repeat the counter to form an encoded counter as a longer bit pattern; an implementation of a first bitwise binary function operative on the first segment and the encoded counter to produce a first result; an implementation of a second bitwise binary function operative on the second segment and the encoded counter to produce a second result; and a combiner to combine the first result, the second result, and the encoded counter to produce the result. The apparatus further comprises an implementation of a secure hash algorithm; means for generating a derivative key from the master key using the implementation of the universal hash algorithm and the secure hash algorithm; and an output port to output the derivative key.
Patent NZ-561857-A (NZ)
Title: Testing harvest readiness of mussels by lipid extraction from sample
Inventor: BROADBENT ANDREW CHRISTOPHER
Filed: 2007-09-25
Abstract: To determine the best time to harvest a mussel crop especially for the extraction of anti-inflammatory medicine from the mussel meat, a sample of the mussels is obtained and an extract of the mussel meat of the sample is processed by supercritical fluid extraction to determine the lipid content of the sample extract. The determined lipid content is compared with a predetermined standard level and if the sample level exceeds the standard level this indicates that the growing mussel population from which the sample was derived is at a suitable stage to be harvested.
Patent NZ-566402-A (NZ)
Title: Synergistic combinations of imazalil and boscalid
Inventor: BYLEMANS DANY LEOPOLD JOZEFIEN
IPC: A01N37/20
Filed: 2006-09-28
Abstract: Disclosed is a composition comprising imazalil, and boscalid in respective proportions to provide a synergistic antifungal effect, and a carrier. Also disclosed is the use of the above composition for protecting plants or their loci, fruit, or seed against fungi. Further disclosed is a product containing (a) a composition comprising imazalil; and (b) a composition comprising boscalid, as a combination for simultaneous or sequential use, wherein said compositions (a) and (b) are in respective proportions to provide a synergistic fungicidal effect.
Patent NZ-569884-A (NZ)
Title: Crystalline form of vinflunine ditartrate
Inventor: MAUREL JEAN-LOUIS
IPC: A61K31/475
Filed: 2006-12-18
Abstract: Disclosed is a crystalline form of vinflunine ditartrate and its physio-chemical properies characterised by infrared spectroscopy and X-ray diffraction spectrum. Also disclosed is a process for preparing the said crystalline form comprising the steps of; - dissolving vinflunine ditartrate in an alcohol/water mixture, - slowly evaporating the solvent mixture at room temperature, in the open air or under vacuum. - filtering and recovering the crystals formed, - rinsing, and drying the crystals under vacuum. Use of the crystalline form of vinflunine ditartrate for the preparation of a medicament for treating cancer is also disclosed.
Patent NZ-570682-A (NZ)
Title: AXMI-006 a delta-endotoxin gene and methods for its use as a pesticide
Inventor: CAROZZI NADINE
IPC: C12N15/82
Filed: 2004-02-20
Abstract: Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a delta-endotoxin polypeptide, designated as AXMI-006 are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated delta-endotoxin nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed.
Patent NZ-571357-A (NZ)
Title: Indolopyridines as EG5 kinesin modulators
Inventor: VENNEMANN MATTHIAS
IPC: A61K31/437
Filed: 2007-02-21
Abstract: Disclosed is a compound of formula 1 wherein the substituents are disclosed within the specification. Also disclosed is the use of the compound of formula 1 in the manufacture of a pharmaceutical composition for modulating EG5 kinesin activity in a mammal in need of said modulation or for treating hyperproliferative diseases responsive to induction of apoptosis including malignant neoplasia or cancer.
Patent NZ-571832-A (NZ)
Title: Sealing ring for sealing a gap between a socket end and a spigot end, the socket end having a circumferential groove for receiving the sealing ring
Inventor: GUSTAFSSON LEIF
IPC: F16L21/035
Filed: 2007-04-18
Abstract: Disclosed is a sealing ring (14) adapted to seal an annular gap (15) between a socket end (11) and a spigot end (12), the socket end having a circumferential groove (13) for receiving the sealing ring. Due to manufacturing tolerances, the radius of the groove is between a minimum value R'min and a maximum value R'max, and the radial gap width of gap is between a minimum value Tmin and a maximum value Tmax. The sealing ring comprises of a sealing element (16) and a holding element (17) which are connected. The holding element is more rigid than the sealing element but is so elastically deformable as to allow insertion of the sealing ring into the groove. The sealing element comprises of a first sealing part (18a and 18b) for sealing against the socket end and a second sealing part (19) for sealing against the spigot end. The first sealing part has a neck portion (18a), which is positioned radially outside the holding element and which supports a radially outer head portion (18b). The outer head portion is positioned radially outside the holding element and has an outer radius which is slightly greater than R'max. The first sealing part is, at the level of the neck portion, bendable in the axial direction (P) along which the spigot end is to be inserted into the socket end. The cross-section of the annular holding element has a radial extent which is greater than 2 x Tmax.
Patent NZ-572611-A (NZ)
Title: Betting system and method
Inventor: FRASER MICHAEL GRANT
IPC: G06Q50/00
Filed: 2007-04-05
Abstract: A data processing system (120) is configured to accept a bet (103) from a participant (101). The data processing system is associated with a betting agency (102) and is configured to receive a bet (103) from the participant wagering an amount in relation to one or more selected potential outcomes of an event (201); receive, from the participant, an indication of one or more modifications to one or more parameters of the bet; and modify the one or more parameters of the bet in accordance with the received indication (290) after commencement of the event and prior to completion of the event (201). A system for a betting agency to accept a bet from a participant in regard to an event having a plurality of competing objects is disclosed. The system includes one or more measurement devices configured to: measure the performance of the competing objects in the event; generate object data indicative of the competing objects performance; and transfer the object data; and the above described data processing system.
Patent NZ-580891-A (NZ)
Title: Methods to control organic contaminants in fibers in paper making systems
Inventor: THOMAS GEORGE S
IPC: D21C9/08
Filed: 2008-05-13
Abstract: Disclosed is a method for controlling deposition of organic contaminants from fibers in paper making systems, comprising contacting said fibers with a composition comprising at least one water-soluble cellulose derivative and at least one ester hydrolysing enzyme, for a sufficient time and in sufficient amount to control the organic contaminants present in the fibers.
Patent NZ-583905-A (NZ)
Title: Use of BAFF to Treat Sepsis
Inventor: HOTCHKISS RICHARD S
IPC: A61P29/00
Filed: 2005-10-13
Abstract: Disclosed is the use of soluble BAFF (B cell activation factor from the TNF family) that promotes B Cell survival in the manufacture of a medicament for the treatment or prevention of sepsis, severe sepsis or septic shock.
Patent NZ-585851-A (NZ)
Title: Electrochemical detection of a metal - labelled analyte
Inventor: PORTER ROBERT ANDREW
IPC: G01N33/543
Filed: 2008-11-25
Abstract: Disclosed is a method for determining the presence or amount of a metal-labelled analyte in a sample, the method including the steps of: adding a release agent to the metal-labelled analyte to release the metal label fromthe analyte, the release agent and the metal label together forming an insoluble charged species, applying a potential to bring the charged species to an electrode, applying a positive potential to the charged species to dissolve the metal label toform metal ions, and carrying out a quantitative determination procedure to determine the presence or amount of the metal-labelled analyte.
Patent NZ-591140-A (NZ)
Title: Fc gamma receptor for the treatment of b cell mediated multiple sclerosis
Inventor: BUCKEL PETER
IPC: A61K38/17
Filed: 2009-09-02
Abstract: The use of a non-glycosylated soluble Fc-gamma receptor for the treatment of multiple sclerosis, wherein the multiple sclerosis is a B cell mediated form of multiple sclerosis or an autoantibody driven form of multiple sclerosis. The receptor can be Fc-gamma RIIB/C (CD32) or FC-gamma RIIIA/B (CD16b).